The Offering is subject to regulatory approval including approval of the TSX Venture Exchange.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.

About Aptilon Corporation
Aptilon enables pharmaceutical, biotech, and medical device companies to effectively reach and interact with physicians via the Internet through its innovative live video detailing (with company reps), e-detailing, e-sampling, peer selling, and other educational content programs. Leading healthcare companies have adopted Aptilon's "Sales Force of the Future" model, driving tens of thousands of high-quality rep-physician interactions averaging 8 to 10 minutes in length. Aptilon provides the necessary infrastructure for sales representatives to build physician awareness, understanding, and preference during all stages of a product life cycle, from pre-launch education through to end-stage support. For more information, visit www.aptilon.com.

Forward-looking Statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.

###

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.